Stay updated on Clinical Trial: Olaparib + Abiraterone in Prostate Cancer
Sign up to get notified when there's something new on the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page.

Latest updates to the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 to the history; removed the Notice about lapse in government funding and Revision: v3.4.1.SummaryDifference0.6%

- Check20 days agoChange DetectedAdded a government funding notice and the latest revision entry (v3.4.1); removed the previous revision entry (v3.4.0) from the history.SummaryDifference0.6%

- Check28 days agoChange DetectedShow glossary feature added and a color-coded legend explaining additions and deletions. The revision note is updated to v3.4.0 and the older No FEAR Act data label and v3.3.4 reference were removed.SummaryDifference0.8%

- Check42 days agoChange DetectedRecord History shows a new revision entry: Revision v3.3.4 replacing v3.3.3, indicating a metadata update to the page history.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.3.3 was added to the history and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed; these changes are limited to metadata and do not affect study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check92 days agoChange DetectedA new Document Section 'Study Status' was added to the Study Record History on 2025-11-20 (Revision: v3.3.2), and a prior revision (v3.2.0) was removed on 2025-08-29. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Clinical Trial: Olaparib + Abiraterone in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Olaparib + Abiraterone in Prostate Cancer page.